Clinical trials
Prostatitis clinical trials
Below are recruiting prostatitis clinical trials, each written for real people, not researchers. We’re tracking 1,360 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07300631Recruiting
SpaceOAR gel use during prostate cancer radiation
This study is a registry that collects information from people receiving standard care with a gel called SpaceOAR during radiation therapy for prostate cancer. It helps doctors learn more about how the gel works in routine practice.
BrestAges 18 years+ - NCT07289243Recruiting
Laser treatment for enlarged prostate symptoms
This trial tests a new laser treatment for an enlarged prostate that has not improved with medication. The goal is to relieve urinary symptoms by removing or shrinking the tissue blocking urine flow.
Bari, ITALY/BariAges 40–85 - NCT07291414Recruiting
Tracking cancer medication safety with a self-monitoring platform
This trial tests a platform where you can track your experiences and concerns about cancer medications. It aims to help you and your care team manage medication safety.
Ann Arbor, MichiganAges 18 years+ - NCT07296887Recruiting
Care tool study for cancer teams and patients
This study tests a new care tool for people with gynecologic, prostate, lung, or colorectal cancer. It helps your care team (doctors, nurses, social workers) and patients like you see if the tool improves support and communication.
Alton, IllinoisAges 18 years+ - NCT07293585RecruitingPhase 3
Precision radiation to protect erectile function in prostate cancer
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
Los Angeles, CaliforniaAges 18 years+ - NCT07292168RecruitingPhase 1/Phase 2
Study of a new antibody for advanced tumors with FGFR1 protein
This trial tests an experimental antibody, OM-RCA-01, in people with advanced solid tumors that have high levels of a protein called FGFR1. It aims to see if the drug is safe and effective for those who have already tried other treatments.
Kazan'Ages 18 years+ - NCT07290270Recruiting
Real-world use of lutetium therapy for advanced prostate cancer
This study follows men with advanced prostate cancer who are receiving a new radioactive treatment called lutetium (177Lu) vipivotide tetraxetan. The goal is to see how well the treatment works in everyday practice, and to gather information on safety and effectiveness.
Shanghai, Shanghai MunicipalityAges 18–99 - NCT07288359RecruitingPhase 1/Phase 2
Study of GVV858 for HR+/HER2- breast cancer and other solid tumors
This trial is testing a new drug, GVV858, either alone or with hormone therapy, for people with HR+/HER2- advanced breast cancer or certain other advanced solid tumors. It may be an option if standard treatments are no longer working or available.
Atlanta, GeorgiaAges 18 years+ - NCT07285044RecruitingPhase 2
Home cancer treatment program for Florida panhandle residents
This study tests whether people with certain cancers can safely receive their regular intravenous treatments at home instead of coming to the clinic. It aims to make treatment more convenient and improve satisfaction, especially for those living in the Florida Panhandle.
Jacksonville, FloridaAges 18 years+ - NCT06865430Recruiting
Managing urinary symptoms after HoLEP surgery
This trial tests if alpha-blocker medication can reduce painful or frequent urination after a prostate surgery called HoLEP. It may help you recover more comfortably.
AnkaraAges 40–85 - NCT06894628Recruiting
Genomics and extreme radiation for recurrent prostate cancer
This study looks at how well a very short course of high-dose radiation works for prostate cancer that has come back after surgery. It aims to learn if genetics can help predict who benefits most from this type of radiation.
RomaAges Any age - NCT07259213RecruitingPhase 1/Phase 2
Study of a new drug (161Tb-RAD402) for men with advanced prostate cancer
This trial tests a new radioactive drug designed to target and destroy prostate cancer cells. It is for men whose cancer has continued to grow despite hormone therapy and other treatments like enzalutamide or abiraterone.
Wollongong, New South WalesAges 18 years+ - NCT06895291Recruiting
Whole body MRI for cancer patients
This study uses whole-body MRI scans to see if they help monitor or diagnose cancer better. It may be an option if your doctor has already recommended this type of scan.
Bologna, BOAges 18 years+ - NCT07253987Recruiting
Cancer Survivors Program for Breast or Prostate Cancer
This study offers a program to help people who have completed their main treatment for early-stage breast or prostate cancer. It focuses on follow-up and support during survivorship, and you are still eligible if you are on certain maintenance therapies like hormone therapy.
BrnoAges 18 years+ - NCT06867588Recruiting
Adding PSMA PET to MRI for prostate cancer detection
This study is testing whether a special scan called a PSMA PET can help find significant prostate cancer in men who are already scheduled for an MRI-guided biopsy. It aims to see if combining the two scans gives a better picture of which prostate areas need to be biopsied.
BrusselsAges 18 years+ - NCT07247175RecruitingPhase 2
Testing force feedback in robotic prostate cancer surgery
This trial is looking at whether a new force-feedback feature in the da Vinci robotic system helps surgeons learn and operate more safely when removing the prostate for prostate cancer.
SoeulAges 19 years+ - NCT06740071Recruiting
Pelvic floor training for urine leakage after prostate surgery
This study tests a special training program using touch and movement to strengthen pelvic floor muscles in men who leak urine after prostate cancer surgery. It may help you regain bladder control more quickly.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07227077Recruiting
Physical activity study for older cancer survivors with chronic pain
This study uses a smartphone program to encourage physical activity in older adults who have survived cancer and have ongoing pain. It aims to learn how to best help you move more and feel better.
Milwaukee, WisconsinAges 65 years+ - NCT07220720RecruitingPhase 2
PET scan for suspicious prostate spots before biopsy
This trial tests whether a special PET scan (called POSLUMA) can help find prostate cancer earlier in men who have an MRI showing a suspicious spot (PIRADS 2 or 3) but haven't yet had a biopsy. If you are scheduled for a biopsy, this scan may give your doctor extra information before the procedure.
Jacksonville, FloridaAges 18–100 - NCT06424912Recruiting
BPH treatment via vein connection for enlarged prostate
This trial tests a new treatment for enlarged prostate (BPH) that targets veins in the scrotum to improve urinary symptoms. It may be an option if you have both BPH and a varicocele and haven't had prior prostate surgery.
Panama City, Provincia de PanamáAges 40–75 - NCT07209176Recruiting
Why men may not get genetic testing for prostate cancer
This study looks at why some men with metastatic prostate cancer do or don't get a genetic test called NGS. It aims to find barriers to testing, so doctors can better help patients in the future.
Baltimore, MarylandAges 18 years+ - NCT07210086RecruitingPhase 2
PET scans to guide radiation for limited metastatic prostate cancer
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
Duarte, CaliforniaAges 18 years+ - NCT06926374Recruiting
Robotic surgery for gastrointestinal and urologic conditions
This trial tests a new robotic surgery system for common operations on the colon, rectum, prostate, kidney, bladder, stomach, esophagus, gallbladder, and hiatal hernia. It may offer a less invasive option for patients who need surgery for these conditions.
Hong KongAges 18–80 - NCT07197723Recruiting
Study of decision making about prostate cancer risk
This study looks at how men with a BRCA1/2 gene change make decisions about their health and prostate cancer risk. Participants will fill out surveys to help researchers understand these choices.
New York, New YorkAges 45–70
Hear when a new Prostatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prostatitis?
- Yes. Clin2 currently lists 1,360 recruiting prostatitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prostatitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prostatitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.